Is There A Role For High Flow
Nasal Therapy In the
Emergency Department?



Wednesday June 3, 2020



12 PM ET; 11 AM CT; 9AM PT



Ruben D Restrepo MD RRT FAARC FCCP

Professor - Division of Respiratory Care

UT Health San Antonio, TX


Ruth Karales, BS, RRT

Manager, Respiratory Care Services

Rush Copley Medical Center, IL

New Online Module

Advisory Board


Aerosol Delivery Devices for Obstructive Lung Disease:
Focus on Nebulizer Systems

By Matt Hegewald, MD


Aerosol therapy is the cornerstone for treating asthma and Chronic Obstructive Pulmonary Disease (COPD).  Many aerosol devices are available, including the pressurized metered dose inhaler, the dry powder inhaler, the slow/soft mist inhaler, and the nebulizer. Each device has its particular advantages and disadvantages. The asthma and COPD guidelines stress the importance of matching the patient to the aerosol delivery device. Providers need to be aware of the advantages and disadvantages of the available devices. Given the absence of evidence that one aerosol delivery system is superior to another, as long as they are used correctly, patient preference, convenience, available drug formulations and cost will be the determining factors in choosing a device. For those patients not capable of using handheld delivery devices adequately, nebulizers are the preferred aerosol delivery devices.


Panel Discussion: New Directions in Aerosol Therapy

Moderator:  Arzu Ari, PhD, RRT, PT, CPFT, FAARC


There has been a growing interest in the development of new aerosol technologies over the years. New directions and technical innovations in aerosol medicine give clinicians access to new devices. However, adopting new aerosol technologies for the treatment of patients with pulmonary diseases brings many challenges and strategic barriers such as unfamiliarity, confusion and misuse of the device by patients due to device dementia as well as lack of knowledge and experience with the novel device in clinical practice. It is important to overcome these barriers for successful implementation of new technologies in aerosol medicine.  In this issue of Clinical Foundations, Drs. Bruce Rubin, James B. Fink and Sandra Adams, who have a wealth of experience and knowledge in aerosol medicine, provide valuable suggestions to clinicians who want to adopt new technologies in their clinical practice. They also provide detailed and comprehensive information on new directions in aerosol medicine, the importance of patient education and adherence, the risks with concomitant therapy and the factors that need to be considered for the selection of a nebulizer. This is your opportunity to improve your knowledge and expertise that will empower you as a clinician for the benefit of your patients.


Click here to download the article

This program is sponsored by Teleflex

Richard Branson, MS, RRT, FAARC

Professor of Surgery

University of Cincinnati College of Medicine

Cincinnati, OH


Kathleen Deakins, MS, RRT, NPS

Supervisor, Pediatric Respiratory Care

Rainbow Babies & Children’s Hospital of University Hospitals

Cleveland, OH


William Galvin, MSEd, RRT, CPFT, AE-C, FAARC

Program Director, Respiratory Care Program

Gwynedd Mercy College,

Gwynedd Valley, PA.


Carl Haas, MS, RRT, FAARC

Educational & Research Coordinator

University Hospitals and Health Centers

Ann Arbor, MI


Richard Kallet, MSc, RRT, FAARC

Clinical Projects Manager

University of California Cardiovascular Research Institute San Francisco, CA


Neil MacIntyre, MD, FAARC

Medical Director of Respiratory Services

Duke University Medical Center

Durham, NC


Tim Myers, BS, RRT-NPS

Chief Business Officer, AARC


Tim Op’t Holt, EdD, RRT, AE-C, FAARC

Professor, Department of Respiratory Care and Cardiopulmonary Sciences University of Southern Alabama

Mobile, AL


Helen Sorenson, MA, RRT, FAARC

Assistant Professor, Dept. of

Respiratory Care

University of Texas Health Sciences Center

San Antonio, TX

Clinical Foundations is published quarterly by
Saxe Healthcare Communications.